Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenocarcinoma Gastric × Ramucirumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 14 Carcinoma, Non-Small-Cell Lung 14 Lung Neoplasms 6 Neoplasm Metastasis 5 Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Adenocarcinoma 3 Thymoma 2 Rectal Neoplasms 2 Non-small Cell Lung Cancer Metastatic 2 Malignant Solid Tumor 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Metastatic Small Intestinal Adenocarcinoma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 HER2-positive Gastric Cancer 1

Interventions

tusamitamab ravtansine 1 Ramucirumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05071053 2025-08-22

CARMEN-GC01

Sanofi

Phase 2 Terminated

35 enrolled 14 charts

Gastrointestinal

Adenocarcinoma Gastric

Data powered by HemOnc (CC BY 4.0) Colophon ⚡